Zhejiang Kanglaite Pharmaceutical Co., Ltd., established by Prof. Li Dapeng, is a 揝tate Key High-tech Enterprise?. Covering an area of 7 hectares and a total floor space of 28,000 sq. m, the LVP production line and auxiliary equipment were introduced from Europe and USA. International GMP standard is strictly followed in production. There are over 500 staff of whom 60% are with university diploma. We have 32 regional offices in China.

As ?State Basic Drug?and 揝tate Medical Insurance Drug? the company mainly produces botanical anticancer drug Kanglaite Injection (KLT) which is a novel dual-function and molecular targeted emulsion with active substance extracted from a TCM herb 搒emen coicis?. KLT has remarkable function in inhibiting and killing cancer cells while strengthening immune function. It has significant effectiveness in controlling cancerous pain, resisting cachexia, preventing cancer metastasis and recurrence, improving KPS, QOL and MST and effectively prolonging patient survival.